Apixaban vs enoxaparin for preventing blood clots after childbirth
Treatments studied
Part of Blood & lymphatic, Women’s health & pregnancy clinical trials.
This trial compares two blood-thinning medicines, apixaban and enoxaparin, to see which works better at preventing dangerous blood clots after delivery. It is for women who have certain risk factors that make them more likely to get a clot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have recently given birth, either vaginally or by cesarean section.
- You need medication to prevent blood clots (prophylaxis).
- You have at least one major risk factor (such as an active infection, heart disease, type 1 diabetes with kidney problems, or an emergency C-section) OR two minor risk factors (such as being over 35, having a BMI over 30, smoking, or having had a twin birth).
- You are not currently breastfeeding.
- You have not had a blood clot before, and you do not have certain bleeding disorders or other conditions that would make these medicines unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a short course of a low-dose blood thinner (heparin) to prevent dangerous blood clots in the legs or lungs after childbirth. It is for women who have certain risk factors that make clots more likely.
This study looks at how a blood thinner called rivaroxaban enters breast milk after delivery. It may help women who need this medication while breastfeeding.
This study tests whether giving a short course of a daily blood-thinning injection (enoxaparin) after childbirth can safely prevent blood clots in women at intermediate risk. If you qualify, you would receive the injection or a placebo (inactive shot) for up to 5 days while in the hospital.
This trial tests if taking aspirin after delivery helps prevent dangerous blood clots in women with certain risk factors. It's for new mothers who have a clotting disorder, were on bed rest, or have multiple other risk factors like high weight or preeclampsia.
This trial studies whether apixaban works as well as enoxaparin to prevent dangerous blood clots after spinal cord injury. If you qualify, you would take one of these medicines to lower clot risk during the recovery period.
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
Hear when a new Postpartum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.